Sanofi to continue opportunistic share buybacks
PARIS Feb 7 (Reuters) - French drugmaker Sanofi plans to continue buying back shares on an opportunistic basis this year, according to slides published on its website ahead of a presentation to analysts on Thursday.
The company repurchased a total of 822 million euros ($1.11 billion) worth of shares last year, according to the slides. ($1 = 0.7387 euros) (Reporting by Elena Berton; Editing by James Regan)
- Islamic State threat 'beyond anything we've seen': Pentagon
- British Muslims blame jihadi subculture after beheading video |
- Israeli air strike kills three Hamas commanders in Gaza |
- U.S. aid workers who survived Ebola leave Atlanta hospital |
- National Guard to withdraw from riot-torn Ferguson, Missouri |